BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Tilbeurgh M, Lemdani K, Beignon AS, Chapon C, Tchitchek N, Cheraitia L, Marcos Lopez E, Pascal Q, Le Grand R, Maisonnasse P, Manet C. Predictive Markers of Immunogenicity and Efficacy for Human Vaccines. Vaccines (Basel) 2021;9:579. [PMID: 34205932 DOI: 10.3390/vaccines9060579] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Rachman A, Iriani A, Irawan C, Sukrisman L, Rajabto W, Mulansari NA, Lubis AM, Prasetyawaty F, Cahyanur R, Priantono D, Rumondor BB, Betsy R, Juanputra S. Complete blood count derived inflammatory biomarkers and the level of anti-SARS-CoV-2 NAb and S-RBD IgG among cancer survivors receiving COVID-19 vaccines. ELECTRON J GEN MED 2023;20:em456. [DOI: 10.29333/ejgm/12851] [Reference Citation Analysis]
2 Plested JS, Zhu M, Cloney-clark S, Massuda E, Patel U, Klindworth A, Massare MJ, Cai R, Fries L, Glenn G, Kalkeri R. Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms 2023;11:368. [DOI: 10.3390/microorganisms11020368] [Reference Citation Analysis]
3 Madi S, Xie F, Farhangi K, Hsu CY, Cheng SH, Aweda T, Radaram B, Slania S, Lambert T, Rambo M, Skedzielewski T, Cole A, Sherina V, McKearnan S, Tran H, Alsaid H, Doan M, Stokes AH, O'Hagan DT, Maruggi G, Bertholet S, Temmerman ST, Johnson R, Jucker BM. MRI/PET multimodal imaging of the innate immune response in skeletal muscle and draining lymph node post vaccination in rats. Front Immunol 2022;13:1081156. [PMID: 36713458 DOI: 10.3389/fimmu.2022.1081156] [Reference Citation Analysis]
4 Ruggeri EM, Nelli F, Giannarelli D, Fabbri A, Giron Berrios JR, Virtuoso A, Marrucci E, Mazzotta M, Schirripa M, Signorelli C, Chilelli MG, Primi F, Fiore C, Panichi V, Topini G, Silvestri MA. Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients. Sci Rep 2022;12:21908. [PMID: 36535985 DOI: 10.1038/s41598-022-25558-8] [Reference Citation Analysis]
5 Talbot SR, Kumstel S, Schulz B, Tang G, Abdelrahman A, Seume N, Wendt EHU, Eichberg J, Häger C, Bleich A, Vollmar B, Zechner D. Robustness of a multivariate composite score when evaluating distress of animal models for gastrointestinal diseases.. [DOI: 10.1101/2022.11.14.516441] [Reference Citation Analysis]
6 Bordi L, Sberna G, Piscioneri CN, Cocchiara RA, Miani A, Grammatico P, Mariani B, Parisi G. Longitudinal dynamics of SARS-CoV-2 anti-receptor binding domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination. Int J Infect Dis 2022;122:174-7. [PMID: 35661687 DOI: 10.1016/j.ijid.2022.05.061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bigay J, Le Grand R, Martinon F, Maisonnasse P. Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development. Front Microbiol 2022;13:932408. [DOI: 10.3389/fmicb.2022.932408] [Reference Citation Analysis]
8 Hadigal S, Colombo L, Haughie S. Reply letter to "Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial". Hum Vaccin Immunother 2022;:2085470. [PMID: 35674507 DOI: 10.1080/21645515.2022.2085470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Polvere I, Parrella A, Zerillo L, Voccola S, Cardinale G, D'Andrea S, Madera JR, Stilo R, Vito P, Zotti T. Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the "Green Pass" Policy. Front Immunol 2022;13:833085. [PMID: 35634315 DOI: 10.3389/fimmu.2022.833085] [Reference Citation Analysis]
10 Isaguliants M, Burt FJ. Perspective Technologies of Vaccination: Do We Still Need Old Vaccines? Vaccines 2022;10:891. [DOI: 10.3390/vaccines10060891] [Reference Citation Analysis]
11 Nelli F, Fabbri A, Panichi V, Giannarelli D, Topini G, Giron Berrios JR, Virtuoso A, Marrucci E, Mazzotta M, Schirripa M, Signorelli C, Chilelli MG, Primi F, Silvestri MA, Ruggeri EM. Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: results from the Vax-On-Profile study. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.108774] [Reference Citation Analysis]
12 Feraoun Y, Palgen JL, Joly C, Tchitchek N, Marcos-Lopez E, Dereuddre-Bosquet N, Gallouet AS, Contreras V, Lévy Y, Martinon F, Le Grand R, Beignon AS. The Route of Vaccine Administration Determines Whether Blood Neutrophils Undergo Long-Term Phenotypic Modifications. Front Immunol 2021;12:784813. [PMID: 35058925 DOI: 10.3389/fimmu.2021.784813] [Reference Citation Analysis]
13 Malik JA, Aroosa M, Ahmed S, Shinde M, Alghamdi S, Almansour K, Hagbani TA, Alanazi MS, Anwar S. SARS-CoV-2 Vaccines: clinical endpoints and psychological perspectives: A literature review. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.03.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Matusali G, Sberna G, Meschi S, Gramigna G, Colavita F, Lapa D, Francalancia M, Bettini A, Capobianchi MR, Puro V, Castilletti C, Vaia F, Bordi L. Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up. Viruses 2022;14:312. [DOI: 10.3390/v14020312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Gianfagna F, Veronesi G, Baj A, Dalla Gasperina D, Siclari S, Drago Ferrante F, Maggi F, Iacoviello L, Ferrario MM. Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection. Sci Rep 2022;12:385. [PMID: 35013457 DOI: 10.1038/s41598-021-04344-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Neustein A, Christen N. Data structures associated with biomedical research. Innovative Data Integration and Conceptual Space Modeling for COVID, Cancer, and Cardiac Care 2022. [DOI: 10.1016/b978-0-32-385197-8.00007-6] [Reference Citation Analysis]
17 Feraoun Y, Palgen J, Joly C, Tchitchek N, Marcos-lopez E, Dereuddre-bosquet N, Gallouet A, Contreras V, Lévy Y, Martinon F, Le Grand R, Beignon A. The route of vaccine administration determines whether blood neutrophils undergo long-term phenotypic modifications.. [DOI: 10.1101/2021.10.26.465872] [Reference Citation Analysis]
18 Held J, Esse J, Tascilar K, Steininger P, Schober K, Irrgang P, Alsalameh R, Tenbusch M, Seggewies C, Bogdan C. Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines (Basel) 2021;9:1063. [PMID: 34696171 DOI: 10.3390/vaccines9101063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
19 Gabashvili IS. Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for an Ambispective study.. [DOI: 10.1101/2021.06.28.21256779] [Cited by in F6Publishing: 1] [Reference Citation Analysis]